Regenxbio (RGNX) Operating Leases (2019 - 2026)
Regenxbio (RGNX) posted Operating Leases of $61.6 million for Q2 2026, down 11.6% from $69.65 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Operating Leases came in at $65.22 million, down 12.0% from FY2024.
- Annual Operating Leases has declined for three consecutive years, with a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
- In prior years, Regenxbio's Operating Leases was $74.13 million in FY2024 (-9.8%), $82.22 million in FY2023 (-7.4%), $88.8 million in FY2022 (+4.6%) and $84.93 million in FY2021 (+21.1%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q3 2020.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2021, with growth of 46.0%; the weakest was Q4 2025, with a decline of 12.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn |
| 10 | Regenxbio | 385.06 Mn | -548.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.60 Mn |
| Dec 31, 2025 | 65.22 Mn |
| Sep 30, 2025 | 67.43 Mn |
| Jun 30, 2025 | 69.65 Mn |
| Mar 31, 2025 | 71.91 Mn |
| Dec 31, 2024 | 74.13 Mn |
| Sep 30, 2024 | 76.34 Mn |
| Jun 30, 2024 | 78.23 Mn |
| Mar 31, 2024 | 80.18 Mn |
| Dec 31, 2023 | 82.22 Mn |
| Sep 30, 2023 | 84.06 Mn |
| Jun 30, 2023 | 85.25 Mn |
| Mar 31, 2023 | 86.99 Mn |
| Dec 31, 2022 | 88.80 Mn |
| Sep 30, 2022 | 84.67 Mn |
| Jun 30, 2022 | 85.67 Mn |
| Mar 31, 2022 | 85.57 Mn |
| Dec 31, 2021 | 84.93 Mn |
| Sep 30, 2021 | 83.88 Mn |
| Jun 30, 2021 | 82.38 Mn |
API Access
Regenxbio Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();